These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22544194)

  • 21. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
    Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
    BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.
    Hingankar NK; Thorat SR; Deshpande A; Rajasekaran S; Chandrasekar C; Kumar S; Srikantiah P; Chaturbhuj DN; Datkar SR; Deshmukh PS; Kulkarni SS; Sane S; Reddy DC; Garg R; Jordan MR; Kabra S; Tripathy SP; Paranjape RS
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S348-54. PubMed ID: 22544202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
    Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
    PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of HIV drug resistance and public health implications in low- and middle-income countries.
    Bertagnolio S; De Luca A; Vitoria M; Essajee S; Penazzato M; Hong SY; McClure C; Duncombe C; Jordan MR
    Antivir Ther; 2012; 17(6):941-53. PubMed ID: 22898622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.
    Hong SY; Jonas A; DeKlerk M; Shiningavamwe A; Desta T; Badi A; Morris L; Hunt GM; Ledwaba J; Sheehan HB; Lau K; Trotter A; Tang AM; Wanke C; Jordan MR
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):463-71. PubMed ID: 25564107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.
    Bennett DE; Myatt M; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():25-36. PubMed ID: 18575189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
    Kamoto K; Aberle-Grasse J;
    Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.
    Ghate M; Kadam D; Gaikwad N; Shankar S; Gurav S; Rahane G; Tanwar S; Rewari B; Gangakhedkar R
    WHO South East Asia J Public Health; 2015; 4(2):123-129. PubMed ID: 28607310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening and enhancing national antiretroviral drug resistance surveillance in Zimbabwe-A country that has reached UNAIDS 95-95-95 amongst adults.
    Dzinamarira T; Moyo E; Moyo B; Murewanhema G; Cuadros D; Kouamou V; Mpofu A; Musuka G
    Front Public Health; 2024; 12():1346027. PubMed ID: 38420022
    [No Abstract]   [Full Text] [Related]  

  • 31. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
    Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
    Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
    Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
    PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean.
    Ravasi G; Jack N; Alonso Gonzalez M; Sued O; Pérez-Rosales MD; Gomez B; Vila M; Riego Ad; Ghidinelli M
    Rev Panam Salud Publica; 2011 Dec; 30(6):657-62. PubMed ID: 22358418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.
    Jordan MR; Bennett DE; Wainberg MA; Havlir D; Hammer S; Yang C; Morris L; Peeters M; Wensing AM; Parkin N; Nachega JB; Phillips A; De Luca A; Geng E; Calmy A; Raizes E; Sandstrom P; Archibald CP; Perriëns J; McClure CM; Hong SY; McMahon JH; Dedes N; Sutherland D; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S245-9. PubMed ID: 22544182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
    Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S
    Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
    Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
    BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.
    Pilgrim NA; Okal J; Matheka J; Mukui I; Kalibala S
    BMC Pediatr; 2018 Jul; 18(1):243. PubMed ID: 30045700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
    Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI
    Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveys of transmitted HIV drug resistance in 7 geographic Regions in China, 2008-2009.
    Liao L; Xing H; Dong Y; Qin G; Ma Y; Lu H; Chen L; Zhang L; Osborne C; Seguy N; Wei D; Sun F; Yang J; Ruan Y; Shao Y
    Clin Infect Dis; 2012 May; 54 Suppl 4():S320-3. PubMed ID: 22544196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.